Brookdale Senior Living Inc. (BKD)
NYSE: BKD · IEX Real-Time Price · USD
7.01
+0.22 (3.24%)
At close: May 1, 2024, 4:00 PM
7.20
+0.19 (2.71%)
After-hours: May 1, 2024, 7:21 PM EDT
Brookdale Senior Living Revenue
In the year 2023, Brookdale Senior Living had annual revenue of $3.02B with 6.74% growth. Revenue in the quarter ending December 31, 2023 was $754.48M with 7.69% year-over-year growth.
Revenue (ttm)
$3.02B
Revenue Growth
+6.74%
P/S Ratio
0.44
Revenue / Employee
$83,773
Employees
36,000
Market Cap
1.33B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.02B | 190.45M | 6.74% |
Dec 31, 2022 | 2.83B | 67.12M | 2.43% |
Dec 31, 2021 | 2.76B | -781.94M | -22.09% |
Dec 31, 2020 | 3.54B | -516.89M | -12.74% |
Dec 31, 2019 | 4.06B | -474.34M | -10.47% |
Dec 31, 2018 | 4.53B | -215.69M | -4.54% |
Dec 31, 2017 | 4.75B | -229.86M | -4.62% |
Dec 31, 2016 | 4.98B | 16.37M | 0.33% |
Dec 31, 2015 | 4.96B | 1.13B | 29.46% |
Dec 31, 2014 | 3.83B | 939.74M | 32.49% |
Dec 31, 2013 | 2.89B | 123.23M | 4.45% |
Dec 31, 2012 | 2.77B | 312.26M | 12.71% |
Dec 31, 2011 | 2.46B | 175.95M | 7.72% |
Dec 31, 2010 | 2.28B | 180.26M | 8.58% |
Dec 31, 2009 | 2.10B | 172.22M | 8.93% |
Dec 31, 2008 | 1.93B | 88.76M | 4.83% |
Dec 31, 2007 | 1.84B | 529.38M | 40.41% |
Dec 31, 2006 | 1.31B | 519.34M | 65.69% |
Dec 31, 2005 | 790.58M | 129.71M | 19.63% |
Dec 31, 2004 | 660.87M | 438.29M | 196.91% |
Dec 31, 2003 | 222.58M | 61.07M | 37.81% |
Dec 31, 2002 | 161.52M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Omnicell | 1.15B |
NovoCure | 509.34M |
Ironwood Pharmaceuticals | 442.74M |
Kiniksa Pharmaceuticals | 301.77M |
Xencor | 168.34M |
Establishment Labs Holdings | 165.15M |
4D Molecular Therapeutics | 20.72M |
Spyre Therapeutics | 886.00K |
BKD News
- 8 days ago - Brookdale Announces Date of First Quarter 2024 Earnings Release and Conference Call - PRNewsWire
- 23 days ago - Brookdale Reports March 2024 Occupancy - PRNewsWire
- 7 weeks ago - Brookdale Reports February 2024 Occupancy - PRNewsWire
- 2 months ago - Brookdale to Present at Citi's 2024 Global Property CEO Conference and Barclays Global Healthcare Conference in March 2024 - PRNewsWire
- 2 months ago - Brookdale Announces Fourth Quarter and Full Year 2023 Results - PRNewsWire
- 3 months ago - Brookdale Announces Details of Fourth Quarter and Full-Year 2023 Earnings Release and Conference Call - PRNewsWire
- 4 months ago - Brookdale Reports December 2023 Occupancy - PRNewsWire
- 4 months ago - Brookdale Announces Beneficial Financing Transactions; Successfully Extends Debt Maturities - PRNewsWire